Efficacy of therapies targeting TGF-β in solid tumors: a systematic review and meta-analysis of clinical trials
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of therapies targeting TGF-β in solid tumors: a systematic review and meta-analysis of clinical trials
Authors
Keywords
-
Journal
Immunotherapy
Volume 15, Issue 4, Pages 283-292
Publisher
Future Medicine Ltd
Online
2023-02-15
DOI
10.2217/imt-2022-0079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGF-β inhibition can overcome cancer primary resistance to PD-1 blockade: A mathematical model
- (2021) Nourridine Siewe et al. PLoS One
- High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition
- (2021) Ying Ni et al. npj Precision Oncology
- Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma
- (2020) Antje Wick et al. INVESTIGATIONAL NEW DRUGS
- Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
- (2020) Hanne Lind et al. Journal for ImmunoTherapy of Cancer
- Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
- (2020) Constance J. Martin et al. Science Translational Medicine
- Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
- (2020) Changhoon Yoo et al. Journal for ImmunoTherapy of Cancer
- Clinical development of therapies targeting TGFβ: current knowledge and future perspectives.
- (2020) D. Ciardiello et al. ANNALS OF ONCOLOGY
- Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
- (2020) Domenico Ribatti et al. Translational Oncology
- EMT, MET, Plasticity, and Tumor Metastasis
- (2020) Basil Bakir et al. TRENDS IN CELL BIOLOGY
- Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort
- (2020) Byoung Chul Cho et al. Journal for ImmunoTherapy of Cancer
- On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
- (2020) Adilson Fonseca Teixeira et al. Frontiers in Cell and Developmental Biology
- Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
- (2020) Julius Strauss et al. Journal for ImmunoTherapy of Cancer
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
- (2019) R.K. Kelley et al. Clinical and Translational Gastroenterology
- Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
- (2019) Xianguang Bai et al. OncoTargets and Therapy
- TGF-β signaling in cell fate control and cancer
- (2019) Yi Yu et al. CURRENT OPINION IN CELL BIOLOGY
- Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer
- (2018) Silvia C. Formenti et al. CLINICAL CANCER RESEARCH
- M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
- (2018) Karin M. Knudson et al. OncoImmunology
- Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
- (2018) Davide Melisi et al. BRITISH JOURNAL OF CANCER
- TGF-β Family Signaling in Tumor Suppression and Cancer Progression
- (2017) Joan Seoane et al. Cold Spring Harbor Perspectives in Biology
- Transforming growth factor-β: A therapeutic target for cancer
- (2017) Sulsal Haque et al. Human Vaccines & Immunotherapeutics
- A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
- (2016) Alba A. Brandes et al. NEURO-ONCOLOGY
- TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
- (2014) D. R. Principe et al. JNCI-Journal of the National Cancer Institute
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression
- (2011) Michael K. Wendt et al. CELL AND TISSUE RESEARCH
- TGF 1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
- (2011) F. Bouquet et al. CLINICAL CANCER RESEARCH
- Switching TGFβ from a tumor suppressor to a tumor promoter
- (2011) Gareth J Inman CURRENT OPINION IN GENETICS & DEVELOPMENT
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
- (2010) Judit Anido et al. CANCER CELL
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
- (2009) Manav Korpal et al. NATURE MEDICINE
- TGFβ in Cancer
- (2008) Joan Massagué CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started